Evidence map›Paper›PMID 41725934›Full record

ArticleFrontiers in cardiovascular medicine2026

Trajectory of cognitive function and quality of life following stenotic aortic valve procedures.

Marco Ranucci, Giuseppe Maria Raffa, Luca Ranucci, Luca Brischigiaro, Stefano Casalino, Vittoria Mazzotta, Martina Anguissola, Oronzo Catalano, Matteo Montorfano, Luca Angelo Ferri and 5 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marco Ranucci *Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Giuseppe Maria Raffa *Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy.
Luca RanucciDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Luca BrischigiaroDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Stefano CasalinoDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Vittoria MazzottaDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Martina AnguissolaDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.
Oronzo CatalanoDepartment of Cardiac Rehabilitation, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
Matteo MontorfanoSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Luca Angelo FerriInterventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Sabrina FerranteDepartment for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy.
Maria Teresa La RovereDepartment of Cardiac Rehabilitation, IRCCS Istituti Clinici Scientifici Maugeri, Montescano, Italy.
Giulio StefaniniCardio Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Ottavia CozziCardio Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Lorenzo MenicantiDepartment of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Severe aortic valve stenosis can be treated with either surgical valve replacement (SAVR) or transcatheter valve implantation (TAVI). The choice between these two strategies is guided by the age and clinical profile of the patient. Our study aims to verify the hypothesis that including health-related quality of life (HRQL) as an outcome measure may be relevant to therapeutic choice. Methods: This prospective observational study included 806 patients aged 65-80 years who received either SAVR or TAVI. HRQL was assessed using the SF-12 questionnaire before and after the procedure (1-4 years of follow-up). Propensity score matching was applied to account for baseline differences between groups, resulting in two matched groups of 92 patients each. A subgroup of 80 patients received a neurocognitive function assessment before the procedure and at 2-3 months of follow-up. Results: At 1-year follow-up, no significant differences were observed between SAVR and TAVI in terms of the mental and physical components of the SF-12, with both procedures resulting in significant improvements in HRQL in both the prematching and propensity-matched populations. In the prematching population, at 4-years follow-up and after adjustment for potential confounders, the cumulative risk of HRQL deterioration did not differ significantly between SAVR and TAVI for the mental component (hazards ratio 1.03, 95% confidence interval 0.69-1.56, Conclusion: In a real-world scenario, no differences in quality of life were observed between SAVR and TAVI at 1-year follow-up; conversely, at 4-year follow-up, the physical component of HRQL appeared to be better preserved in patients undergoing SAVR.

Indexed as

aortic valve stenosisneurocognitive functionquality of lifesurgical aortic valve replacementtranscatheter aortic valve implantation

Identifiers

PMID41725934
PMCPMC12920561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.